bg
A

Akari Therapeutics - ADR (AKTX)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD
barakagetbaraka.com

About Akari Therapeutics - ADR (AKTX)

Akari Therapeutics, Plc is a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory diseases. The Company's lead asset, investigational nomacopan, is a bispecific recombinant inhibitor of complement C5 activati... Read more

  • USD0.27
  • USD0.28
  • USD0.26
  • USD1.73
  • -40.40%
  • --
  • 1.08M
  • 1.75M
  • 12M
  • 0.22
  • -72.90%